Plerixafor

MOZOBIL®

Overview

Plerixafor is a bone marrow stimulating medication used in the treatment of different kinds of cancer. 

SparkCures ID 4
Brand Name Mozobil®
Generic Name Plerixafor
Additional Names AMD3100
Treatment Classifications
  • CXC Chemokine Receptor Type 4 (CXCR4) Inhibitor

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.